Lakeside (LSH)
Distributes pharmaceutical and medical products in China through Hupan Pharmaceutical.
Something off on this page? Send us feedback.
Distributes infusion products, specialty prescription drugs, and medical-nutrition products in China through Hupan Pharmaceutical. Revenue comes from product sales to hospitals, distributors, clinics, and other health-care providers, with pharmaceutical distribution as the sole continuing operating segment.
Distributes infusion products, specialty prescription drugs, and medical-nutrition products in China through Hupan Pharmaceutical (Hubei) Co., Ltd., which operates from Wuhan within a Nevada holding-company structure headquartered in Itasca, Illinois. The unit buys from manufacturers, holds products at designated warehouses, and delivers them to hospitals, distributors, clinics, and other health-care providers, often through agents.
Generates revenue from product sales, with manufacturer costs net of discounts and rebates forming cost of revenue. The continuing business depends on pharmaceutical-operation licensing, market-regulation and drug-administration inspections, government bidding and procurement practices, supplier access, customer relationships, and working-capital timing between receivables, supplier terms, and inventory prepayments. It is the sole reportable and continuing operating segment following the disposal of the former logistics subsidiary.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Mar 31, 2026Cash & short-term investments $1.3M · Total debt $561.6K · Total assets $17.8M · Shareholders' equity $13.6M
- Revenue
- $1.3M
- Operating income
- −$1.6M
- Net income
- −$1.5M
No dividends on record.
| Institutions | 1.89% | 650.3K shares | |
|---|---|---|---|
| 7 holders · as of Jun 30, 2026 | |||
| Other | 98.11% | 33.78M shares | |
| remainder | |||
34.43M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Vanguard Capital Management LLCInstitution | 0.86% | 295,675 | as of Jun 30, 2026 |
Geode Capital Management, LLCInstitution | 0.49% | 170,411 | as of Jun 30, 2026 |
Vanguard Fiduciary Trust CoInstitution | 0.39% | 135,121 | as of Jun 30, 2026 |
Northern Trust CorpInstitution | 0.09% | 32,690 | as of Jun 30, 2026 |
Virtu Financial LLCInstitution | 0.03% | 10,410 | as of Jun 30, 2026 |
Insider tradesForm 4
Nothing filed in the last 12 months.
Not reported.